HPV Testing in NYC and Long Island

Following a positive or invalid HPV result

A positive HPV result means the assay detected a high-risk type; it is not a diagnosis of cancer. The genotype, cervical cell findings when available and earlier results guide follow-up. You may need repeat testing, a cervical specimen or colposcopy. An invalid result means the sample did not yield a usable answer and may require recollection. Ask which step is needed, when it should happen and which service will receive the referral. New bleeding or pain still needs assessment. The result cannot establish the time or source of infection.

HPV testing and cervical screening

HPV testing most commonly supports cervical cancer screening by looking for high-risk HPV types that can lead to cell changes. It differs from a Pap test, which examines cervical cells. A positive HPV result does not mean cancer. The value of the visit is choosing the right screening method and arranging the correct follow-up, rather than ordering a test for every possible HPV exposure.

How HPV testing and cervical screening works

HPV is common, and many infections clear without causing disease. Persistent high-risk infection can increase cervical precancer and cancer risk. A screening assay detects particular high-risk types in a validated specimen. It does not establish when infection began, identify a partner who transmitted it or assess HPV throughout the entire body. Genital warts and a cervical screening result are different clinical issues.

Eligibility: HPV testing and cervical screening

Screening eligibility depends on age, whether a cervix is present, prior screening or treatment and conditions such as HIV or immune suppression. Guidelines and authorized assays have different age and interval pathways. A clinician should select the applicable pathway rather than promising one interval to everyone. Bleeding after sex, postmenopausal bleeding, persistent discharge or pain needs symptom assessment even when a screening result was recently negative.

What to expect: HPV testing and cervical screening

Review anatomy and screening history

Bring prior Pap/HPV reports, cervical procedures, hysterectomy details, HIV/immune history and symptoms. Gender identity does not replace knowing whether a cervix is present or what screening is needed.

Choose a validated collection method

A clinician-collected cervical specimen may support HPV testing, cytology or both. Authorized vaginal self-collection is an option in defined settings and with compatible devices and assays. The service must confirm the actual pathway.

Understand the result

A positive result means a high-risk type was detected, not that cancer is present. Genotype, prior results and any cell findings guide whether repeat testing, a cervical specimen or colposcopy is needed.

Complete follow-up

Make a dated plan with a named receiving service if colposcopy or other assessment is required. A portal result without follow-up is an incomplete screening pathway.

Preparing for your appointment

Bring actual screening reports and tell the clinician about pregnancy, vaginal medicines, bleeding or discomfort with pelvic exams. Ask whether the proposed test needs a speculum exam, whether self-collection is suitable and which assay will be used. Follow collection-specific preparation instructions; do not assume a home kit and a clinician-collected sample have identical requirements.

Risks and when to seek help

HPV testing is not a routine general STI screen for every person, partner, genital wart or oral exposure. A negative cervical test does not exclude HPV at all sites. Vaccination lowers risk from covered types but does not replace recommended cervical screening. New symptoms or a visible lesion needs examination and appropriate diagnostic care.

Follow-up and treatment review

Positive results often lead to surveillance or further assessment rather than immediate treatment. Follow-up depends on the precise result and previous history, so avoid assigning yourself a repeat date based on another patient’s experience. An invalid sample may require recollection. Keep records across clinic changes so the next clinician can decide using the full history.

Appointments, costs and coverage

Confirm whether the location provides cervical collection, validated self-collection, laboratory testing or referral for colposcopy. Ask which HPV collection method is provided. Ask about screening, laboratory and follow-up costs, along with communication and referral arrangements. Request symptom evaluation rather than a screening-only booking when symptoms are the concern.

Medical sources

• CDC HPV guidance
• NCI abnormal HPV and Pap results
• FDA cobas HPV self-collection authorization
• NCI self-collection screening guidance
• Human Papillomavirus Disease: Adult and Adolescent OIs | NIH